<?xml version="1.0" encoding="UTF-8"?>
<p>These drugs are nucleic acid analogs, similar to ACV with a shared mechanism of action that interferes with the function of the viral DNA polymerase (
 <xref rid="B42" ref-type="bibr">De Clercq, 2013</xref>). These compounds differ from each other mainly in their bioavailability, half-life in the body and dosing (
 <xref rid="B195" ref-type="bibr">Wagstaff and Bryson, 1994</xref>), yet similar to ACV they reduce herpetic lesions and associated pain in approximately 1â€“3 days, as compared to untreated groups when used topically (
 <xref rid="B53" ref-type="bibr">Emmert, 2000</xref>).
</p>
